Federal Register / Vol. 73, No. 18 / Monday, January 28, 2008 / Notices 4877 

equally likely to be pre-existing widely 

established claims, novel claims, or preexisting claims that are not widely 

established, then we can expect 667 of 

each of these types of claims to be 

substantiated per year. Table 1 of this 

document shows that the annual burden 

hours associated with assembling 

evidence for claims is 189,428 (the sum 

of 667 x 44 hours, 667 x 120 hours, and 

667 x 120 hours). 

There are no capital costs or operating 

and maintenance costs associated with 

this information collection. 

Please note that on January 15, 2008, 

the FDA Web site transitioned to the 

Federal Dockets Management System 

(FDMS). FDMS is a Government-wide, 

electronic docket management system. 

Electronic submissions will be accepted 

by FDA through FDMS only. 

Dated: January 18, 2008. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E8–1362 Filed 1–25–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Advisory Council on the 

National Health Service Corps 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: Correction of meeting date. 

SUMMARY: The Health Resources and 

Services Administration published a 

meeting notice for the National 

Advisory Council on the National 

Health Service Corps in the Federal 

Register of January 15, 2008 (FR Doc. 

E8–581), on page 2510. The beginning 

date of the meeting has changed. 

Correction 

In the Federal Register issue of 

January 15, 2008, (FR Doc. E8–581), on 

page 2510 under the category Dates and 

Times, the new meeting dates are 

February 29, 2008, 8:30 a.m.–5 p.m. and 

March 1, 2008, 9 a.m.–5 p.m. 

Dated: January 22, 2008. 

Alexandra Huttinger, 

Acting Director, Division of Policy Review 

and Coordination. 

[FR Doc. E8–1371 Filed 1–25–08; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Statement of Organization, Functions 

and Delegations of Authority 

This notice amends Part R of the 

Statement of Organization, Functions 

and Delegations of Authority of the 

Department of Health and Human 

Services (HHS), Health Resources and 

Services Administration (HRSA) (60 FR 

56605–56606 as amended November 6, 

1995; and as last amended at 72 FR 

57588–57589, dated October 10, 2007.) 

This notice reflects organizational 

changes in the Health Resources and 

Services Administration, Office of the 

Administrator, Office of 

Communications (RA6). Specifically, 

this notice updates the functional 

statement of the Office of the 

Administrator, Office of 

Communications (RA6). 

Chapter RA, Office of the Administrator 

Section RA–10, Organization 

The Offices under the Immediate 

Office of the Administrator consist of 

the following components: 

(1) Immediate Office of the 

Administrator (RA); 

(2) Office of Equal Opportunity and 

Civil Rights (RA2); 

(3) Office of Planning and Evaluation 

(RA5); 

(4) Office of Communications (RA6); 

(5) Office of Minority Health and 

Health Disparities (RA9); 

(6) Office Legislation (RAE); 

(7) Office of Information Technology 

(RAG); and 

(8) Office of International Health 

Affairs (RAH). 

Section RA–20, Functions 

Delete the functional statement for the 

Office of Communications (RA6) in its 

entirety and replace it with the 

following: 

Office of Communications (RA6) 

(1) Provides leadership and 

coordinates communications and public 

affairs activities for the Agency; (2) 

coordinates Agency communications 

activities with those of other health 

agencies within the Department of 

Health and Human Services and with 

field, State, local, voluntary, and 

professional organizations; (3) develops 

and implements national 

communications initiatives to inform 

and educate the public, health care 

professionals, policy makers, and the 

media; (4) coordinates, researches, 

writes and prepares speeches and 

audiovisual presentations for the HRSA 

Administrator and other senior HRSA 

staff; (5) provides communication and 

public affairs expertise to the Agency 

consistent with policy direction 

established by the HHS Assistant 

Secretary for Public Affairs; (6) 

develops, obtains clearance for, and 

publicizes press releases and media 

briefs, fact sheets and other news and 

information items describing Agency 

programs and services; (7) serves as 

Communications and Public Affairs 

Officer for the Agency including 

establishment and maintenance of 

productive relationships with the news 

media; (8) reviews and edits all Agency 

publications and promotional materials 

and oversees all Agency exhibits; (9) 

handles all public requests for release of 

HRSA information and records under 

the Freedom of Information Act; (10) 

manages the Agency Web information 

content, function, and design and leads 

the development of Agency Internet 

content policies; and (11) manages 

audio visual and multimedia activities 

in support of Agency communication 

efforts. 

Section RC–30, Delegations of Authority 

All delegations of authority and redelegations of authority made to HRSA 

officials that were in effect immediately 

prior to this reorganization, and that are 

consistent with this reorganization, 

shall continue in effect pending further 

re-delegation. 

This reorganization is effective upon 

the date of signature. 

Dated: January 15, 2008. 

Elizabeth M. Duke, 

Administrator. 

[FR Doc. E8–1370 Filed 1–25–08; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

mstockstill on PROD1PC66 with NOTICES

4878 Federal Register / Vol. 73, No. 18 / Monday, January 28, 2008 / Notices 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cardiovascular 

Sciences Integrated Review Group, Clinical 

and Integrative Cardiovascular Sciences 

Study Section. 

Date: February 7–8, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Russell T. Dowell, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4128, 

MSC 7814, Bethesda, MD 20892, (301) 435–

1850, dowellr@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group, Ethical, 

Legal, and Social Implications of Human 

Genetics Study Section. 

Date: February 13–14, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Cheryl M. Corsaro, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2204, 

MSC 7890, Bethesda, MD 20892, (301) 435–

1045, corsaroc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Vascular 

Biology. 

Date: February 14, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Bukhtiar H. Shah, DVM, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4095J, 

MSC 7822, Bethesda, MD 20892, (301) 435–

1233, shahb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Innovative 

Ultrasound and Imaging. 

Date: February 18, 2008. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Bay Drive, San Diego, CA 92109. 

Contact Person: Antonio Sastre, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5215, 

MSC 7412, Bethesda, MD 20892, (301) 435–

2592, sastrea@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Electromagnetic Devices. 

Date: February 18, 2008. 

Time: 4 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Bay Drive, San Diego, CA 92109. 

Contact Person: Antonio Sastre, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5215, 

MSC 7412, Bethesda, MD 20892, (301) 435–

2592, sastrea@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cancer 

Diagnostics and Treatments I SBIR/STTR. 

Date: February 20–21, 2008. 

Time: 11 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Hungyi Shau, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, 301–435–

1720, shauhung@cfr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cancer 

Diagnostics and Treatments II SBIR/STTR. 

Date: February 20, 2008. 

Time: 11 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Hungyi Shau, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, 301–435–

1720, shauhung@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cancer 

Genetics and Genomics SEP. 

Date: February 20, 2008. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Steven B. Scholnick, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–435–

1719, scholnis@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflicts in Cognition, Perception, and 

Language. 

Date: February 21, 2008. 

Time: 1:30 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Alfonso R. Latoni, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3182, 

MSC 7848, Bethesda, MD 20892, 301–435–

0913, latonia@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Bioengineering Research Partnerships. 

Date: February 25, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ramada Rockville/The Legacy Hotel, 

1775 Rockville Pike, Rockville, MD 20852. 

Contact Person: John Firrell, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5213, 

MSC 7854, Bethesda, MD 20892, 301–435–

2598, firrellj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Health 

Promotion Programs for Older Workers SBIR 

Study Section. 

Date: February 25, 2008. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Karin F. Helmers, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3148, 

MSC 7770, Bethesda, MD 20892, 301–435–

1017, helmersk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Hypersensitivity, Autoimmune, and Immunemediated Diseases: Member Conflicts and 

Overflow. 

Date: February 27–28, 2008. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Stephen M. Nigida, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4212, 

MSC 7812, Bethesda, MD 20892, 301–435–

1222, nigidas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cancer Drug 

Development and Therapeutics 1 SBIR/ 

STTR. 

Date: February 27–28, 2008. 

Time: 11 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Hungyi Shau, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, 301–435–

1720, shauhung@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Pain and Somatosensory. 

Date: February 28–29, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 73, No. 18 / Monday, January 28, 2008 / Notices 4879 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Joseph G. Rudolph, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, 301–435–

2212, josephru@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 F09–

B (20) Oncology Fellowship. 

Date: February 28–29, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Ritz-Carlton, 1150 22nd Street, 

NW., Washington, DC 20037. 

Contact Person: Eun Ah Cho, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6202, 

MSC 7804, Bethesda, MD 20892, (301) 451–

4467, choe@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Diabetes, 

Obesity and Nutrition. 

Date: February 28, 2008. 

Time: 10 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Krish Krishnan, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6164, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1041, krishnak@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Drug 

Discovery. 

Date: February 28, 2008. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Manzoor Zarger, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6208, 

MSC 7804, Bethesda, MD 20892, (301) 435–

2477, zargerma@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Oncology 

AREA. 

Date: February 29, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Lambratu Rahman, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 451–

3493, rahmanl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Fellowship: 

Sensory, Motor and Cognitive Neuroscience. 

Date: February 29, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Washington DC, 

1250 22nd Street, NW., Washington, DC 

20037. 

Contact Person: John Bishop, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5180, 

MSC 7844, Bethesda, MD 20892, (301) 435–

1250, bishopj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Radiology 

Oncology. 

Date: February 29, 2008. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Manzoor Zarger, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6208, 

MSC 7804, Bethesda, MD 20892, (301) 435–

2477, zargerma@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

January 18, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–299 Filed 1–25–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice if hereby given of a change in 

the meeting of the Integrative and 

Clinical Endocrinology and 

Reproduction Study Section, February 

4, 2008, 8 a.m. to February 5, 2008, 

3 p.m., Bethesda Marriott, 5151 Pooks 

Hill Road, Bethesda, MD, 20814 which 

was published in the Federal Register 

on January 15, 2008, 73 FR 2513–2516. 

The meeting will be held at the Hyatt 

Regency Bethesda, One Bethesda Metro 

Center, 7400 Wisconsin Avenue, 

Bethesda, MD 20814. The meeting dates 

and time remain the same. The meeting 

is closed to the public. 

Dated: January 18, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–300 Filed 1–25–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Nanotechnology Imaging and Sensing 

Platforms for Improved Diagnosis of Cancer. 

Date: March 7, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Executive Plaza North, 6130 Executive Blvd., 

EPN Conference Room ‘H’, Rockville, MD 

20852. 

Contact Person: Kenneth L. Bielat, PhD, 

Scientific Review Administrator, Special 

Review Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Suite 

703, Room 7147, Bethesda, MD 20892–8329, 

301-496–7576, bielatk@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, ‘‘Cancer 

Prevention Research Small Grant Program’’. 

Date: March 13–14, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9737 Washington 

Blvd., Gaithersburg, MD 20878. 

Contact Person: Gerald G. Lovinger, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8101, Bethesda, MD 20892–8329, 301/496–

7987, lovingeg@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Small 

Grants Program for Cancer Epidemiology. 

Date: March 27–28, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Legacy Rockville, 1775 

Rockville Pike, Rockville, MD 20852. 

mstockstill on PROD1PC66 with NOTICES